MedPath

role of frozen sock

Not Applicable
Recruiting
Conditions
Neoplasms
Registration Number
KCT0002662
Lead Sponsor
Kangbuk Samsung Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

histopathologically proven breast cancer patients aged from 20 to 75
-AJCC stage T0-T4, N1-N2, M0
-ECOG Performance status 0 or 1
-are planning for adjuvant chemotherapy
-are planning for neoadjuvant chemotherapy
-are planning for docetaxel administration at doses between 75 mg/m2 and 100 mg/m2 as a 90 minutesintravenous infusion every 3 weeks, either alone or in combination with other cytotoxic agents

Exclusion Criteria

-Raynaud syndrome
-history of peripheral neuropathy (grade 2)
-history of chemotherapy with taxane agents (docetaxel, paclitaxel, nab-paclitaxel)
-skin or ungual disorder
-distant metastasis
-cold intolerance
-arteriopathy
-history of hypersensitivity to docetaxel
-enrolled in the other clinical study

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Peripheral neuropathy- motor nerve (peroneal, tibial) and sensory nerve (superficial peroneal, medial plantar, sural) conduction study
Secondary Outcome Measures
NameTimeMethod
skin and nail disorder
© Copyright 2025. All Rights Reserved by MedPath